Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Susnik

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Clinical Breast Cancer|July 19, 2016
Surgical Outcomes of Lobular Neoplasia Diagnosed in Core Biopsy: Prospective Study of 316 CasesBarbara Susnik, Deborah Day, Ellen Abeln, et al.
International Journal of Breast Cancer|June 14, 2021
HER2 Testing Characteristics Can Predict Residual Cancer Burden following Neoadjuvant Chemotherapy in HER2-Positive Breast CancerTamera J Lillemoe, Mara Rendi, Michaela L Tsai, et al.
Clinical Breast Cancer|August 3, 2020
Effects of Germline Pathogenic Variants, Cancer Subtypes, Tumor-related Characteristics, and Pregnancy-associated Diagnosis on OutcomesMichaela L Tsai, Monica Knaack, Parker Martone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Hypermethylated genes as biomarkers of cancer in women with pathologic nipple dischargeMary Jo Fackler, Aeisha Rivers, Wei Wen Teo, et al.
Breast Cancer Research and Treatment|January 19, 2008
HER2 in well differentiated breast cancer: is testing necessary?G Kenneth Haines, Elizabeth Wiley, Barbara Susnik, et al.
Annals of Surgical Oncology|June 15, 2007
Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breastAndrea V Barrio, Bradly D Clark, Jessica I Goldberg, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 20, 2021
HER2 Testing: Insights From Pathologists' Perspective on Technically Challenging HER2 FISH CasesErin V Grimm, Kimberly H Allison, David G Hicks, et al.
Science Translational Medicine|March 8, 2023
Immature natural killer cells promote progression of triple-negative breast cancerGatha Thacker, Samantha Henry, Ajeya Nandi, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Clinical Breast Cancer|July 19, 2016
Surgical Outcomes of Lobular Neoplasia Diagnosed in Core Biopsy: Prospective Study of 316 CasesBarbara Susnik, Deborah Day, Ellen Abeln, et al.
International Journal of Breast Cancer|June 14, 2021
HER2 Testing Characteristics Can Predict Residual Cancer Burden following Neoadjuvant Chemotherapy in HER2-Positive Breast CancerTamera J Lillemoe, Mara Rendi, Michaela L Tsai, et al.
Clinical Breast Cancer|August 3, 2020
Effects of Germline Pathogenic Variants, Cancer Subtypes, Tumor-related Characteristics, and Pregnancy-associated Diagnosis on OutcomesMichaela L Tsai, Monica Knaack, Parker Martone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Hypermethylated genes as biomarkers of cancer in women with pathologic nipple dischargeMary Jo Fackler, Aeisha Rivers, Wei Wen Teo, et al.
Breast Cancer Research and Treatment|January 19, 2008
HER2 in well differentiated breast cancer: is testing necessary?G Kenneth Haines, Elizabeth Wiley, Barbara Susnik, et al.
Annals of Surgical Oncology|June 15, 2007
Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breastAndrea V Barrio, Bradly D Clark, Jessica I Goldberg, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 20, 2021
HER2 Testing: Insights From Pathologists' Perspective on Technically Challenging HER2 FISH CasesErin V Grimm, Kimberly H Allison, David G Hicks, et al.
Science Translational Medicine|March 8, 2023
Immature natural killer cells promote progression of triple-negative breast cancerGatha Thacker, Samantha Henry, Ajeya Nandi, et al.
Pageof 3